TY - STD TI - O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist. 2014. http://amr-review.org/Publications. UR - http://amr-review.org/Publications ID - ref1 ER - TY - BOOK AU - Mossialos, E. AU - Morel, C. M. AU - Edwards, S. AU - Berenson, J. AU - Gemmill-Toyama, M. AU - Brogan, D. PY - 2010 DA - 2010// TI - Policies and Incentives for Promoting Innovation in Antibiotic Research PB - World Health Organization and Swedish Ministry of Social affairs and Health CY - Copenhagen ID - Mossialos2010 ER - TY - BOOK AU - Matthiessen, L. PY - 2015 DA - 2015// TI - Infectious Disease Financing Facility (IDFF). Horizon 2020 SC1 Advisory Group for the “Health, demographic change and well-being” PB - European Commission CY - Brussels ID - Matthiessen2015 ER - TY - BOOK AU - O’Neill, J. PY - 2015 DA - 2015// TI - Securing New Drugs for Future Generations: The Pipeline of Antibiotics PB - Wellcome Trust CY - London ID - O’Neill2015 ER - TY - STD TI - Renwick M, Brogan D, Mossialos E. A Critical Assessment of Incentive Strategies for Development of Novel Antibiotics. J Antibiot. 2015; doi: 10.1038/ja.2015.98 ID - ref5 ER - TY - JOUR AU - Morel, C. M. AU - Mossialos, E. PY - 2010 DA - 2010// TI - Stoking the antibiotic pipeline JO - BMJ VL - 18 UR - https://doi.org/10.1136/bmj.c2115 DO - 10.1136/bmj.c2115 ID - Morel2010 ER - TY - BOOK AU - Sharma, P. AU - Towse, A. PY - 2010 DA - 2010// TI - New drugs to tackle antimicrobial resistance: analysis of EU policy options PB - Office of Health Economics CY - London ID - Sharma2010 ER - TY - JOUR AU - Munos, B. PY - 2009 DA - 2009// TI - Lessons from 60 years of pharmaceutical innovation JO - Nat Rev Drug Discov VL - 8 UR - https://doi.org/10.1038/nrd2961 DO - 10.1038/nrd2961 ID - Munos2009 ER - TY - BOOK AU - Cecchini, M. AU - Langer, J. AU - Slawomirski, L. PY - 2015 DA - 2015// TI - Antimicrobial Resistance in G7 Countries and Beyond: Economic Issues, Policies and Options for Action PB - Organization for Economic Co-operation and Development CY - Paris ID - Cecchini2015 ER - TY - STD TI - Harper M. The Truly Staggering Cost of Inventing New Drugs. Forbes, 2012. Available from: www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/#2715e4857a0b70d756604477. Accessed on October 7, 2015. UR - http://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/#2715e4857a0b70d756604477 ID - ref10 ER - TY - BOOK PY - 2014 DA - 2014// TI - Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs PB - D Cost Study Briefing CY - Boston ID - ref11 ER - TY - JOUR AU - Avorn, J. PY - 2015 DA - 2015// TI - The $2.6 Billion Pill—Methodologic and Policy Considerations JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMp1500848 DO - 10.1056/NEJMp1500848 ID - Avorn2015 ER - TY - JOUR AU - Monnet, D. L. PY - 2005 DA - 2005// TI - Antibiotic development and the changing role of the pharmaceutical industry JO - Int J Risk Safety Med VL - 17 ID - Monnet2005 ER - TY - BOOK PY - 2015 DA - 2015// TI - The IMI funding model Innovative Medicines Initiative PB - European Commission CY - Brussels ID - ref14 ER - TY - JOUR AU - Elmer, C. AU - Grossenbacher, T. AU - Gruhnwald, S. AU - Schafer, M. PY - 2015 DA - 2015// TI - The People Pay, Corporations Cash In: Problems Plague EU Medical Research Initiative JO - Der Spiegel VL - 1 ID - Elmer2015 ER - TY - JOUR AU - Garattini, S. AU - Bertele, V. AU - Bertolini, G. PY - 2013 DA - 2013// TI - A failed attempt at collaboration JO - BMJ VL - 347 UR - https://doi.org/10.1136/bmj.f5354 DO - 10.1136/bmj.f5354 ID - Garattini2013 ER - TY - JOUR AU - Brogan, D. AU - Mossialos, E. PY - 2006 DA - 2006// TI - Applying the concepts of financial options to stimulate vaccine development JO - Nat Rev Drug Discov VL - 5 UR - https://doi.org/10.1038/nrd2035 DO - 10.1038/nrd2035 ID - Brogan2006 ER - TY - JOUR AU - Brogan, D. M. AU - Mossialos, E. PY - 2013 DA - 2013// TI - Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model JO - Glob Health VL - 9 UR - https://doi.org/10.1186/1744-8603-9-58 DO - 10.1186/1744-8603-9-58 ID - Brogan2013 ER - TY - JOUR AU - Russell, P. K. PY - 2007 DA - 2007// TI - Project BioShield: what it is, why it is needed, and its accomplishments so far JO - Clin Infect Dis VL - 45 UR - https://doi.org/10.1086/518151 DO - 10.1086/518151 ID - Russell2007 ER - TY - BOOK PY - 2014 DA - 2014// TI - Publicly Financed Global Consortium for R&D to Fight Antibiotic Resistance PB - World Health Organization CY - Geneva ID - ref20 ER - TY - BOOK PY - 2013 DA - 2013// TI - Strategic Research Agenda PB - Joint Programming Initiative on Antimicrobial Resistance CY - The Hague ID - ref21 ER -